Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Vincent Calvez, Diane Descamps, Jacques Reynes, Mark Wainberg, Brett Begemann, Gregory Weaver


Theradiag has named four members of its newly formed scientific advisory board who will help the company develop a microRNA-based diagnostic for characterizing HIV tropism.

Members of the SAB include Vincent Calvez, a virologist at Pitie Salpetriere Hospital in Paris; Diane Descamps, a researcher at Paris-Diderot University who specializes in HIV resistance; Jacques Reynes, a professor at the University Hospital of Montpellier who studies HIV/AIDS; and Mark Wainberg, director of the McGill AIDS Center at Quebec Jewish General Hospital.

Monsanto has named Brett Begemann as its new president and COO. He most recently served as the company's president and chief commercial officer.

In his expanded role, Begemann will continue to oversee Monsanto's worldwide sales and operations, but will now handle corporate affairs, as well.

Atossa Genetics has appointed Gregory Weaver to its board of directors and named him as a member of its audit committee.

Weaver previously served as CFO of Sirna Therapeutics prior to its acquisition by Merck.